» Authors » Thomas F Stoop

Thomas F Stoop

Explore the profile of Thomas F Stoop including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 37
Citations 223
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Ishida H, Franklin O, Franco S, Clark T, Stoop T, Kirsch M, et al.
Ann Surg . 2025 Mar; PMID: 40047068
Objective: To investigate complications and survival following surgical resection for pancreatic cancer with arterial encasement. Summary Background Data: Surgery for pancreatic cancer with extensive involvement (encasement) of the major visceral...
2.
Seelen L, Augustinus S, Stoop T, Bouwense S, Busch O, Cirkel G, et al.
J Natl Compr Canc Netw . 2025 Feb; 23(3):97-104. PMID: 39970867
Background: Health care providers of patients with cancer should discuss the impact of treatment, such as multiagent chemotherapy and surgery, on quality of life (QoL). However, in the era of...
3.
Javed A, Habib J, Andel P, Campbell B, Rompen I, Mahmud O, et al.
Ann Surg . 2025 Feb; PMID: 39928537
Objective: The aim of the study was to investigate prognostic factors in context of neoadjuvant therapy (NAT) and develop tools that can allow for accurate and personalized patient prognostication. Summary...
4.
Rompen I, Stoop T, van Roessel S, van Veldhuisen E, Janssen Q, Alseidi A, et al.
Ann Surg . 2025 Jan; PMID: 39886770
Aim: To validate the prognostic value of the PAncreatic NeoAdjuvant MAssachusetts (PANAMA)-score and to determine its predictive ability for survival benefit derived from adjuvant treatment in patients after resection of...
5.
Stoop T, Sugawara T, Oba A, Feld I, van Roessel S, van Veldhuisen E, et al.
JAMA Oncol . 2025 Jan; PMID: 39847363
Importance: The effect of adjuvant chemotherapy following resection of pancreatic adenocarcinoma after preoperative (m)FOLFIRINOX (combination leucovorin calcium [folinic acid], fluorouracil, irinotecan hydrochloride, and oxaliplatin in full or modified dosing) chemotherapy...
6.
Stoop T, Molnar A, Seelen L, Sugawara T, Scheepens J, Ali M, et al.
Ann Surg . 2025 Jan; PMID: 39846439
Objective: To investigate whether tangential versus segmental portomesenteric venous resection (PVR) impacts surgical and oncological outcome in patients undergoing pancreatoduodenectomy for pancreatic cancer with portomesenteric vein (PMV) involvement. Summary Background...
7.
Ishida H, Watanabe S, Franco S, Franklin O, Stoop T, Kirsch M, et al.
Ann Surg . 2024 Dec; PMID: 39676646
Objective: To investigate the incidence and risk factors of portomesenteric venous thrombosis (PVT) after pancreatic cancer surgery with portomesenteric venous resection (PVR). Summary Background Data: Pancreatic cancer surgery with PVR...
8.
9.
Rompen I, Habib J, Kinny-Koster B, Campbell B, Stoop T, Kummerli C, et al.
Ann Surg . 2024 Sep; PMID: 39291382
Aim: To investigate the impact of total pancreatectomy (TP) on oncological outcomes for patients at high-risk of local recurrence or secondary progression in the remnant gland after partial pancreatectomy (PP)...
10.
Javed A, Rompen I, van Goor I, Stoop T, Andel P, Mahmud O, et al.
Ann Surg . 2024 Sep; PMID: 39286904
Objective: To measure the rate of LTS in resected PDAC and determine the association between predictors of OS and LTS. Summary Background Data: Long-term survival (>5 y, LTS) remains rare...